Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SyntheMed’s Cardiac Anti-Adhesion Barrier Gets FDA Panel Date

This article was originally published in The Gray Sheet

Executive Summary

FDA's Circulatory System Devices Panel will meet Sept. 19 to consider and vote on a PMA for SyntheMed's Repel-CV surgical anti-adhesion film

You may also be interested in...



CryoCor Plans Launch After Gaining Approval For Cryoablation System

CryoCor plans to begin marketing its cryoablation system for atrial flutter over the next several months, the firm announced Aug. 2

CryoCor Plans Launch After Gaining Approval For Cryoablation System

CryoCor plans to begin marketing its cryoablation system for atrial flutter over the next several months, the firm announced Aug. 2

FDA Dispute Panel Rebuffs Cardima’s Catheter A-Fib Claims

An FDA dispute resolution body all but halted Cardima's chances to turn around the fortunes of its Revelation Tx microcatheter NavAblator ablation system April 19, voting 5-0 not to recommend approval of the product

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025086

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel